RNTX
Price
$1.14
Change
-$0.01 (-0.87%)
Updated
Aug 7, 10:46 AM (EDT)
Capitalization
26.62M
VYGR
Price
$3.40
Change
-$0.01 (-0.29%)
Updated
Aug 7, 11:00 AM (EDT)
Capitalization
188.14M
103 days until earnings call
Interact to see
Advertisement

RNTX vs VYGR

Header iconRNTX vs VYGR Comparison
Open Charts RNTX vs VYGRBanner chart's image
Rein Therapeutics
Price$1.14
Change-$0.01 (-0.87%)
Volume$2.25K
Capitalization26.62M
Voyager Therapeutics
Price$3.40
Change-$0.01 (-0.29%)
Volume$700
Capitalization188.14M
RNTX vs VYGR Comparison Chart in %
Loading...
RNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RNTX vs. VYGR commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNTX is a Hold and VYGR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 07, 2025
Stock price -- (RNTX: $1.15 vs. VYGR: $3.40)
Brand notoriety: RNTX and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNTX: 29% vs. VYGR: 115%
Market capitalization -- RNTX: $26.62M vs. VYGR: $188.14M
RNTX [@Biotechnology] is valued at $26.62M. VYGR’s [@Biotechnology] market capitalization is $188.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $210.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNTX’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 2 green FA rating(s).

  • RNTX’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 2 green, 3 red.
According to our system of comparison, VYGR is a better buy in the long-term than RNTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNTX’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 8 bullish TA indicator(s).

  • RNTX’s TA Score: 4 bullish, 4 bearish.
  • VYGR’s TA Score: 8 bullish, 1 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than RNTX.

Price Growth

RNTX (@Biotechnology) experienced а -9.06% price change this week, while VYGR (@Biotechnology) price change was -1.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.67%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +14.10%.

Reported Earning Dates

VYGR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($188M) has a higher market cap than RNTX($26.6M). VYGR YTD gains are higher at: -40.035 vs. RNTX (-49.783). RNTX has higher annual earnings (EBITDA): -26.51M vs. VYGR (-97.25M). VYGR has more cash in the bank: 236M vs. RNTX (7.43M). VYGR has higher revenues than RNTX: VYGR (67M) vs RNTX (0).
RNTXVYGRRNTX / VYGR
Capitalization26.6M188M14%
EBITDA-26.51M-97.25M27%
Gain YTD-49.783-40.035124%
P/E RatioN/A6.00-
Revenue067M-
Total Cash7.43M236M3%
Total DebtN/A42M-
FUNDAMENTALS RATINGS
RNTX vs VYGR: Fundamental Ratings
RNTX
VYGR
OUTLOOK RATING
1..100
5814
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
32
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
9364
P/E GROWTH RATING
1..100
10010
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (32) in the Biotechnology industry is in the same range as RNTX (49) in the null industry. This means that VYGR’s stock grew similarly to RNTX’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RNTX (100) in the null industry. This means that VYGR’s stock grew similarly to RNTX’s over the last 12 months.

VYGR's SMR Rating (96) in the Biotechnology industry is in the same range as RNTX (100) in the null industry. This means that VYGR’s stock grew similarly to RNTX’s over the last 12 months.

VYGR's Price Growth Rating (64) in the Biotechnology industry is in the same range as RNTX (93) in the null industry. This means that VYGR’s stock grew similarly to RNTX’s over the last 12 months.

VYGR's P/E Growth Rating (10) in the Biotechnology industry is significantly better than the same rating for RNTX (100) in the null industry. This means that VYGR’s stock grew significantly faster than RNTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RNTXVYGR
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
RNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BZH23.300.20
+0.87%
Beazer Homes USA
VALE9.85-0.02
-0.20%
Vale SA
IONR2.97-0.01
-0.34%
ioneer Ltd
HUN9.24-0.28
-2.94%
Huntsman Corp
ANY0.51-0.02
-3.64%
Sphere 3D Corp

RNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNTX has been loosely correlated with NBY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if RNTX jumps, then NBY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNTX
1D Price
Change %
RNTX100%
-2.12%
NBY - RNTX
35%
Loosely correlated
-3.30%
ERNA - RNTX
27%
Poorly correlated
-0.59%
IKT - RNTX
27%
Poorly correlated
-3.89%
ATOS - RNTX
26%
Poorly correlated
-2.14%
VYGR - RNTX
25%
Poorly correlated
+0.59%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+0.59%
RGNX - VYGR
50%
Loosely correlated
-0.72%
KYMR - VYGR
49%
Loosely correlated
-3.77%
XNCR - VYGR
49%
Loosely correlated
-5.79%
TRDA - VYGR
49%
Loosely correlated
+2.06%
XENE - VYGR
47%
Loosely correlated
-0.38%
More